DE2649095C2 - - Google Patents

Info

Publication number
DE2649095C2
DE2649095C2 DE2649095A DE2649095A DE2649095C2 DE 2649095 C2 DE2649095 C2 DE 2649095C2 DE 2649095 A DE2649095 A DE 2649095A DE 2649095 A DE2649095 A DE 2649095A DE 2649095 C2 DE2649095 C2 DE 2649095C2
Authority
DE
Germany
Prior art keywords
ophthalmic
solution
cornea
solutions
tear film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2649095A
Other languages
German (de)
English (en)
Other versions
DE2649095A1 (de
Inventor
Gerald Hecht
Charles Dean Forth Worth Tex. Us Shively
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of DE2649095A1 publication Critical patent/DE2649095A1/de
Application granted granted Critical
Publication of DE2649095C2 publication Critical patent/DE2649095C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eyeglasses (AREA)
DE19762649095 1975-12-04 1976-10-28 Fuer kuenstliche traenen geeignete loesung fuer die ophthalmologische anwendung Granted DE2649095A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/637,608 US4039662A (en) 1975-12-04 1975-12-04 Ophthalmic solution

Publications (2)

Publication Number Publication Date
DE2649095A1 DE2649095A1 (de) 1977-06-16
DE2649095C2 true DE2649095C2 (enExample) 1988-09-08

Family

ID=24556657

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762649095 Granted DE2649095A1 (de) 1975-12-04 1976-10-28 Fuer kuenstliche traenen geeignete loesung fuer die ophthalmologische anwendung

Country Status (5)

Country Link
US (1) US4039662A (enExample)
JP (1) JPS5929167B2 (enExample)
CA (1) CA1071104A (enExample)
DE (1) DE2649095A1 (enExample)
FR (1) FR2333500A1 (enExample)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5428810A (en) * 1977-08-01 1979-03-03 American Home Prod Pharmaceutical composition for eye disease containing 1*33dioxoo1hhbenzo *d * e* isoquinolinee2*3h**acetic acid
US4168112A (en) * 1978-01-05 1979-09-18 Polymer Technology Corporation Contact lens with a hydrophilic, polyelectrolyte complex coating and method for forming same
US4287175A (en) * 1978-06-22 1981-09-01 Merck & Co., Inc. Contact lens wetting agents
US4238482A (en) * 1978-09-29 1980-12-09 Peyman Gholam A Intraocular infusion irrigation solution and method
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4371522A (en) * 1979-04-25 1983-02-01 Gilbard Jeffrey P Keratoconjunctivitis sicca therapy
US4271144A (en) * 1979-06-06 1981-06-02 Holles Laboratories, Inc. Dextran composition for controlling corneal hydration
US4597965A (en) * 1979-06-06 1986-07-01 Holles Laboratories, Inc. Method and composition for controlling corneal hydration
US4436730A (en) 1979-06-25 1984-03-13 Polymer Technology Corporation Ionic opthalmic cellulose polymer solutions
DE3102207A1 (de) 1980-01-29 1981-11-19 Mitsubishi Denki K.K., Tokyo Funkenerrosionsbearbeitungsloesung und deren anwendung
EP0050644B1 (en) * 1980-04-25 1985-09-18 A/S Orthana Kemisk Fabrik Sterilized, preserved, stable mucine-containing solutions and sterilization method
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation
US5209927A (en) * 1985-01-23 1993-05-11 Alcon Laboratories, Inc. Ophthalmic solution
US4826871A (en) * 1985-03-13 1989-05-02 Gressel Philip D Topical ophthalmic compositions containing one or more retinoids
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
US4883658A (en) * 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4966773A (en) * 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
AU1936788A (en) * 1987-06-01 1989-01-04 Allergan, Inc. Preservative free ophthalmic ointments
US5614545A (en) * 1988-06-09 1997-03-25 Leonard Bloom Topical composition for treatment of blepharitis
US5165918A (en) * 1988-06-28 1992-11-24 Ciba-Geigy Corporation Antimicrobial ophthalmic solutions containing dodecyl-dimethyl-(2 phenoxyethyl)-ammonium bromide and methods of using the same
JP2530491B2 (ja) * 1988-12-20 1996-09-04 参天製薬株式会社 ヒアルロン酸点眼液
US5627162A (en) * 1990-01-11 1997-05-06 Gwon; Arlene E. Methods and means for control of proliferation of remnant cells following surgery
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
WO1992003133A1 (en) * 1990-08-16 1992-03-05 Bloom, Leonard Topical treatment of blepharitis
US5460834A (en) * 1991-12-13 1995-10-24 Alcon Laboratories, Inc. Combinations of polymers for use in physiological tear compositions
US5331496A (en) * 1992-02-14 1994-07-19 Digital Equipment Corporation Thin-film magnetic transducer with a multitude of magnetic flux interactions
WO1993017664A1 (en) * 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions
DE4209722C3 (de) * 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Tropfbares Gel für die Augenheilkunde
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
CA2125060C (en) * 1993-07-02 1999-03-30 Henry P. Dabrowski Ophthalmic solution for artificial tears
US5382599A (en) * 1993-10-13 1995-01-17 Allergan, Inc. Method of inhibiting protozoan growth in eye care products using a polyvalent cation chelating agent
US5494817A (en) * 1993-12-06 1996-02-27 Allergan, Inc. Sugar-based protease composition for use with constant-PH borate buffers
NL9400160A (nl) * 1994-02-02 1995-09-01 Stichting Tech Wetenschapp Therapeutische samenstelling voor het vervangen en/of aanvullen van lichaamsvloeistoffen.
US5895645A (en) * 1995-01-31 1999-04-20 Bausch & Lomb Incorporated Opthalmic solution for artificial tears
CA2235069C (en) * 1995-10-19 2010-12-14 Advanced Reproduction Technologies, Inc. Methods and compositions to improve germ cell and embryo survival and function
US5882687A (en) * 1997-01-10 1999-03-16 Allergan Compositions and methods for storing contact lenses
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
IT1298758B1 (it) * 1998-03-19 2000-02-02 Angelini Ricerche Spa Soluzione umettante e lubrificante per uso oftalmico
AR035509A1 (es) 2000-12-21 2004-06-02 Alcon Inc Solucion de lagrimas artificiales mejorada que contiene una combinacion de tres emolientes y el uso de dicha solucion para la fabricacion de un medicamento
US6828356B2 (en) * 2002-07-29 2004-12-07 Ast Products, Inc. Preparation of ophthalmic compositions
US6806364B2 (en) * 2002-07-29 2004-10-19 Ast Products, Inc. Ophthalmic compositions
CA2526467C (en) * 2003-05-20 2015-03-03 Kagutech Ltd. Digital backplane recursive feedback control
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US7914803B2 (en) 2003-06-13 2011-03-29 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of three polymers
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
CA2839930C (en) * 2003-06-13 2016-07-05 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
EP1696878A1 (en) * 2003-12-11 2006-09-06 Alcon, Inc. Ophthalmic compositions containing a polysaccharide/borate gelling system
WO2005115475A1 (ja) * 2004-05-27 2005-12-08 Santen Pharmaceutical Co., Ltd. 眼科用粘稠化剤
US20080307751A1 (en) * 2004-10-01 2008-12-18 Newman Stephen D Contact Lens Package Solution
US20070059274A1 (en) * 2004-12-01 2007-03-15 Bahram Asgharian Ophthalmic compositions containing a PVA/borate gelling system
US8703198B2 (en) * 2005-03-02 2014-04-22 Aquatrove Biosciences Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof
US20100233295A1 (en) * 2005-03-02 2010-09-16 Vibha Gupta Aqueous moisturizers and lubricants and uses thereof
ITRM20050443A1 (it) * 2005-08-12 2007-02-13 Opocrin Spa Preparati oftalmici a base di polisaccaridi mucoadesivi con capacita' riepitelizzante della cornea.
US20070238789A1 (en) * 2006-03-31 2007-10-11 Chin-Ming Chang Prednisolone acetate compositions
US20080021068A1 (en) * 2006-07-24 2008-01-24 Akorn, Inc. Aqueous gel formulation and method for inducing topical anesthesia
US20080057023A1 (en) * 2006-08-29 2008-03-06 Chynn Emil W Oxygenated ophthalmic composition
KR101555291B1 (ko) * 2007-02-09 2015-09-30 알콘, 인코퍼레이티드 세가지 폴리머의 상승성 배합물을 함유하는 안과 조성물
MX2010003364A (es) * 2007-10-08 2010-07-06 Lux Biosciences Inc Composiciones oftalmicas que comprenden inhibidores de calcineurina o inhibidores de mtor.
US20090131303A1 (en) * 2007-11-16 2009-05-21 Bor-Shyue Hong Methods and compositions for treating dry eye
AU2010259184B2 (en) 2009-06-09 2015-08-13 Aurinia Pharmaceuticals Inc. Topical drug delivery systems for ophthalmic use
RU2404779C1 (ru) * 2009-11-02 2010-11-27 Государственное учреждение "УФИМСКИЙ НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ИНСТИТУТ ГЛАЗНЫХ БОЛЕЗНЕЙ" Академии наук Республики Башкортостан (УфНИИ ГБ АН РБ) Глазная лекарственная пленка
US9439981B2 (en) * 2011-07-29 2016-09-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for increasing the intraocular pressure in an animal
RU2581025C1 (ru) * 2015-02-09 2016-04-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации Глазная лекарственная пленка с моксифлоксацином
US10010502B2 (en) 2015-05-19 2018-07-03 Amorphex Therapeutics Llc Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
US20230277694A1 (en) * 2022-03-04 2023-09-07 Harrow Ip, Llc Ophthalmic dye composition and method for administering same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2853414A (en) * 1953-12-02 1958-09-23 American Sugar Refining Co Water-insoluble complex of quaternary ammonium salt, a heavy-metal oxide, and an organic colloid and method of preparing same

Also Published As

Publication number Publication date
JPS5929167B2 (ja) 1984-07-18
FR2333500A1 (fr) 1977-07-01
US4039662A (en) 1977-08-02
DE2649095A1 (de) 1977-06-16
FR2333500B1 (enExample) 1982-08-06
JPS5270015A (en) 1977-06-10
CA1071104A (en) 1980-02-05

Similar Documents

Publication Publication Date Title
DE2649095C2 (enExample)
DE69828993T2 (de) Kontrollierte abgabe von pharmazeutika in der vorderen augenkammer
DE69620724T2 (de) Ophthalmische Formulierung auf Natriumhyaluronatbasis zur Verwendung in der Augenchirurgie
DE69522550T2 (de) Flüssiges ophthalmologisches abgabesystem mit verzögerter freisetzung
DE69513902T2 (de) Augenpräparat zur Verwendung in künstlicher Tränenflüssigkeit
DE69909768T2 (de) Xanthangummi enthaltende gelbildende ophthalmische zusammensetzungen
DE69831962T2 (de) Ophthalmische zusammensetzungen für weiche kontaklinsen enthaltend terpenoid
DE69805531T2 (de) Ophthalmische arzneizubereitung enthaltend ein kationisches glycosid und ein anionisches arzneimittel
EP1455803B2 (de) Verwendung von panthenol und/oder panthothensäure und hyaluronsäure/und oder hyaluronat zur herstellung einer pharmazeutischen zusammensetzung zur ophtalmologischen anwendung
DE3507024C2 (de) Lösung zur Augenbehandlung
DE60117009T2 (de) Verwendung einer wässrigen Lösung zur Behandlung von Trockenaugen
DE3721163A1 (de) Traegermaterial fuer augenarzneimittel
DE3734835C2 (de) Verwendung einer im wesentlichen isotonischen Lösung zur Behandlung und Linderung von Augenkrankheiten
DE69706410T2 (de) Mit tamarindensamenpolysacchariden verdickte opthalmische lösungen
DE69115990T2 (de) Zusammensetzung zur Behandlung von Dry Eye Erkrankungen
DE602004003812T2 (de) Ophthalmische zusammensetzungen mit einer synergistischen kombination von drei polymeren
DE102016203696A1 (de) Ophthalmologische Zusammensetzung
DE60108727T2 (de) Farbige visko-elastische zusammensetzung
EP1453523B1 (de) Heparin-haltiges ophthalmikum
WO1997038674A1 (de) Ophthalmische zusammensetzung mit verlängerter verweilzeit am auge
DE69427573T2 (de) Ophthalmische Suspensionen enthaltend Difluprednate
DE60221227T2 (de) Xanthangummi enthaltende reepithelialisierende pharmazeutische Zubereitungen
DE2918799A1 (de) Ophthalmische loesung
DE60205913T2 (de) Ophthalmische zubereitung mit n-acetylcystein zur behandlung trockener augen
DE69333005T2 (de) Zusammensetzungen von hyaluronat mit bimodalem molekulargewicht und verfahren zu deren verwendung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition